newsUK CMA disqualifies pharma company director after breaking competition law15 June 2020 | By Victoria Rees (European Pharmaceutical Review)A pharmaceutical company director is now banned from holding a director role at any UK company for the next five years after making illegal arrangements.
newsCMA levels over £3.4m in fines for competition law breaches5 March 2020 | By Hannah Balfour (European Pharmaceutical Review)The UK’s Competition and Markets Authority (CMA) has fined four companies in because of anti-competitive practices in the supply of nortriptyline.
newsTwo drug firms admit to colluding to keep prices up24 September 2019 | By Rachael Harper (European Pharmaceutical Review)King Pharmaceuticals Limited and Alissa Healthcare Research Limited have admitted to sharing information to keep drug prices up.
newsFour pharmaceutical companies accused of illegal anti-competitive conduct20 June 2019 | By European Pharmaceutical ReviewThe CMA has revealed findings that provisionally show that four pharmaceutical companies have broken the law.
newsAntidepressant could slow Parkinson’s disease6 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)Nortriptyline, which has been used to treat depression has been found to stop the growth of abnormal proteins on the brain...
